Januvia and Cogentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Januvia (sitagliptin phosphate) and Cogentin (benztropine mesylate). Common drug interactions include diarrhoea among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Januvia and Cogentin. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Januvia?

Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.

What is Cogentin?

Cogentin has active ingredients of benztropine mesylate. It is often used in tardive dyskinesia. eHealthMe is studying from 7,692 Cogentin users. Check the latest studies of Cogentin.



On Jul, 06, 2026

26 people who take Januvia and Cogentin together, and have interactions are studied.

Januvia and Cogentin drug interactions.

What are the common drug interactions of Januvia and Cogentin, by gender? *:

female:

  1. Diarrhoea
  2. Dyskinesia (abnormality or impairment of voluntary movement)
  3. Hypersomnia (excessive daytime sleepiness (eds))
  4. Multiple injuries
  5. Nausea (feeling of having an urge to vomit)
  6. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  7. Staphylococcus test positive
  8. Aspartate aminotransferase increased
  9. Blood calcium decreased
  10. Blood magnesium decreased

male:

  1. Back pain
  2. Abnormal behaviour
  3. Muscle tightness
  4. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  5. Speech disorder
  6. Anaemia (lack of blood)
  7. Anaemia macrocytic (a macrocytic class of anaemia)
  8. Arthralgia (joint pain)
  9. Benign prostatic hyperplasia (benign enlargement of the prostate)
  10. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)

What are the common drug interactions of Januvia and Cogentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anaemia (lack of blood)
  2. Anaemia macrocytic (a macrocytic class of anaemia)
  3. Blood glucose increased
  4. Blood lactate dehydrogenase increased
  5. Chest pain
  6. Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
  7. Cogwheel rigidity (tension in a muscle which gives way in little jerks when the muscle is stretched)
  8. Dystonia (abnormal muscle tone)
  9. Glycosylated haemoglobin increased
  10. Herpes zoster

20-29:

n/a

30-39:

  1. Ill-defined disorder
  2. Depression
  3. Suicide attempt
  4. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
  5. Blood glucose fluctuation
  6. Cardiovascular disorder (heart diseases)
  7. Overdose
  8. Weight increased

40-49:

  1. Drug screen positive
  2. Hypersensitivity

50-59:

  1. Suicidal ideation
  2. Transaminases increased
  3. Blood pressure increased
  4. Chest pain
  5. Feeling of body temperature change
  6. Flushing (the warm, red condition of human skin)
  7. Infusion related reaction
  8. Sinus bradycardia (an unusually slow heartbeat due to heart disease)

60+:

  1. Dyskinesia (abnormality or impairment of voluntary movement)
  2. Arthralgia (joint pain)
  3. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  4. Pain
  5. Rash
  6. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  7. Abnormal behaviour
  8. Activities of daily living impaired
  9. Aortic arteriosclerosis (hardening of the aortic arteries)
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 8 people, 30.77%
  2. Type 2 Diabetes: 3 people, 11.54%
  3. Pain: 3 people, 11.54%
  4. Sleep Disorder: 2 people, 7.69%
  5. Psychotic Disorder: 2 people, 7.69%
  6. Lipidosis (disorder of lipid metabolism involving abnormal accumulation of lipids in the reticuloendothelial cells): 2 people, 7.69%
  7. Insomnia (sleeplessness): 2 people, 7.69%
  8. Indigestion: 2 people, 7.69%
  9. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 7.69%
  10. Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Januvia and Cogentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Januvia and Cogentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Januvia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cogentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Januvia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cogentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sitagliptin phosphate and benztropine mesylate (the active ingredients of Januvia and Cogentin, respectively), and Januvia and Cogentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: